ArticleACS omega2026
The Effect of Protecting Groups and Peptide Chain Length on the Aqueous Solubility of l‑Alanine Homopeptides.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The solubility of peptides is a critical physicochemical parameter governing both upstream solid-phase peptide synthesis (SPPS) route optimization and downstream crystallization design. In this study, the aqueous solubility of l-alanine and its homologous oligopeptides bearing Boc and Cbz N-terminal protecting groups was systematically determined from 278.15 K to 313.15 K using the gravimetric method. N-capped peptide fragments exhibited aqueous solubility 90% lower than their unprotected counterparts, demonstrating that hydrophobic protecting groups substantially suppress aqueous dissolution. Notably, dialanine exhibited a 1.72-fold solubility enhancement relative to alanine at 298.15 K, and retrograde solubility behavior was observed for the first time for trialanine and tetraalanine. These anomalous findings were rigorously interpreted through analyses of solid-state crystal packing, thermodynamic properties, and molecular interactions. Experimental solubility data were correlated using the modified Apelblat equation. Complementary molecular dynamics simulations were employed to elucidate the intramolecular hydrogen-bonding networks. This work presents the first comprehensive solubility dataset for N-protected peptide fragments, offering physicochemical insights to inform protecting group selection and the development of downstream crystallization strategies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.